Global Clinical Trial Supply Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Clinical Trial Supply Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Clinical Phase Type (Phase 1, Phase 2, Phase 3, and Others), Product Type (Manufacturing, Storage and Distribution- Cold Chain Based/Non-Cold Chain Based, and Supply Chain Management), End-Users (Pharmaceuticals, Biologics, Medical Devices, and Others), Application (Oncology, CNS, Infectious Disease, Metabolic Disorder, Cardiovascular, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Clinical Trial Supply Market was valued at USD 2,315.2 million in 2023 and is expected to reach USD 3,831.7 million by 2031 while growing at a CAGR of 6.5% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global clinical trial supply market growth. Clinical trial supply involves providing pharmaceutical products, including investigational drugs and medical devices, for research studies that assess the safety and effectiveness of new treatments in human subjects. This process includes managing and distributing materials to trial sites where participants are enrolled.
Increasing numbers of clinical trials and an expanding biopharmaceutical pipeline are expected to drive substantial growth in the Clinical Trial Supply market. However, the market's expansion may encounter obstacles such as regulatory compliance and stringent guidelines, along with drug shortages and supply interruptions.
Furthermore, the global clinical trial supply industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Clinical Phase Type Analysis
The Global Clinical Trial Supply Market is segmented among Phase 1, Phase 2, Phase 3, and Others, based on Clinical Phase Type. In 2023, Phase 3 accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Product Type Analysis
The Global Clinical Trial Supply Market is segmented among Manufacturing, Storage and Distribution- Cold Chain Based/Non-Cold Chain Based, and Supply Chain Management, based on Product Type. In 2023, Supply Chain Management accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Clinical Trial Supply Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Thermo Fisher Scientific, Catalent, Inc., Parexel, Almac Group, Marken, Piramal Pharma Solutions, UDG Healthcare, Recipharm, Myonex, and Rubicon.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Clinical Trial Supply Market Dynamics
Drivers
Restraints
Opportunity
4. Global Clinical Trial Supply Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Clinical Trial Supply Market Segmentation, By Clinical Phase Type
Global Clinical Trial Supply Market Share Analysis, By Clinical Phase Type
Global Clinical Trial Supply Market Growth Analysis, By Clinical Phase Type
Global Clinical Trial Supply Market Trends, By Clinical Phase Type
o Phase 1
o Phase 2
o Phase 3
o Others
6. Global Clinical Trial Supply Market Segmentation, By Product Type
Global Clinical Trial Supply Market Share Analysis, By Product Type
Global Clinical Trial Supply Market Growth Analysis, By Product Type
Global Clinical Trial Supply Market Trends, By Product Type
o Manufacturing
o Storage and Distribution- Cold Chain Based/Non-Cold Chain Based
o Supply Chain Management
7. Global Clinical Trial Supply Market Segmentation, By End-Users
Global Clinical Trial Supply Market Share Analysis, By End-Users
Global Clinical Trial Supply Market Growth Analysis, By End-Users
Global Clinical Trial Supply Market Trends, By End-Users
o Pharmaceuticals
o Biologics
o Medical Devices
o Others
8. Global Clinical Trial Supply Market Segmentation, By Application
Global Clinical Trial Supply Market Share Analysis, By Application
Global Clinical Trial Supply Market Growth Analysis, By Application
Global Clinical Trial Supply Market Trends, By Application
o Oncology
o CNS
o Infectious Disease
o Metabolic Disorder
o Cardiovascular
o Others
9. Global Clinical Trial Supply Market Segmentation, By Region
Global Clinical Trial Supply Market Share Analysis, By Region
Global Clinical Trial Supply Market Growth Analysis, By Region
Global Clinical Trial Supply Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
10. Competitive Landscape
Thermo Fisher Scientific*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Catalent, Inc.
Parexel
Almac Group
Marken
Piramal Pharma Solutions
UDG Healthcare
Recipharm
Myonex
Rubicon
*Similar analysis will be provided for each company listed above.
